The 340B drug pricing program is a vital lifeline for safety-net hospitals and health centers, but pharmaceutical companies are restricting its use, which is causing a health crisis for families in need, and the 340B PATIENTS Act is needed to protect the program and ensure access to affordable medicine, care, and support.
